Surgeons in training can stabilize their complication rate after approximately 100 cases, according to a speaker at the ...
An FDA complete response letter for idebenone in LHON indicates unresolved NDA deficiencies and necessitates additional data ...
Even in an era of remarkable therapeutics for neovascular age-related macular degeneration, there remains a lack of therapies ...
The implantable extraocular neuromuscular stimulator, i-NYS, as the world's first and only approved Class III active implantable medical device for treating congenital nystagmus, is the result of over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results